Basis of Presentation (Details) - Schedule of Diluted Loss per Share - shares	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	2,487,515	1,455,148
Convertible Notes Payable [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	8,277	308,287
Warrant [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	598,267	153,653
Stock options [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	1,880,971	993,208

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration